Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

0Tip RSCInsights

Authors

Robert Coleman•David Dodwell12 more•Helen Marshall

Journal

The Lancet Oncology

Published

July 15, 2014

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Oncology

Medicine

Internal Medicine

Adjuvant Therapy

Intention-To-Treat Analysis

Show all topics

DOI

10.1016/s1470-2045(14)70302-x

License

Unknown License